Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youfang Cao

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Clinical Pharmacology and Therapeutics|April 5, 2023
Factors Influencing COVID-19 Risk: Insights From Molnupiravir Exposure-Response Modeling of Clinical OutcomesAkshita Chawla, Ruthie Birger, Hong Wan, et al.
NPJ Systems Biology and Applications|March 6, 2026
Neuro-Dynamic Quantitative Systems Pharmacology (QSP) model describing Alzheimer's disease pathophysiology and treatment effectsYoufang Cao, Brian A Willis, Kanta Horie, et al.
Science Signaling|April 14, 2016
Gβ promotes pheromone receptor polarization and yeast chemotropism by inhibiting receptor phosphorylationAmber Ismael, Wei Tian, Nicholas Waszczak, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 29, 2024
Population pharmacokinetics and exposure-response analyses of safety (ARIA-E and isolated ARIA-H) of lecanemab in subjects with early Alzheimer's diseaseOneeb Majid, Youfang Cao, Brian A Willis, et al.
Plos Computational Biology|June 9, 2021
Mechanistic basis of post-treatment control of SIV after anti-α4β7 antibody therapyChad R Wells, Youfang Cao, David P Durham, et al.
The ISME Journal|October 30, 2009
Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in miceChenhong Zhang, Menghui Zhang, Shengyue Wang, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2022
Safety and Pharmacokinetics of Islatravir in Individuals with Severe Renal InsufficiencyRandolph P Matthews, Youfang Cao, Munjal Patel, et al.
Nature Medicine|April 18, 2017
HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapyJenna B Honeycutt, William O Thayer, Caroline E Baker, et al.
Clinical Pharmacology and Therapeutics|September 16, 2023
Artificial Intelligence for Quantitative Modeling in Drug Discovery and Development: An Innovation and Quality Consortium Perspective on Use Cases and Best PracticesNadia Terranova, Didier Renard, Mohamed H Shahin, et al.
Clinical and Translational Science|March 26, 2025
Comparison of Molnupiravir Exposure-Response Relationships for Virology Response and Mechanism of Action Biomarkers With Clinical Outcomes in Treatment of COVID-19Akshita Chawla, Ruthie Birger, Brian M Maas, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Clinical Pharmacology and Therapeutics|April 5, 2023
Factors Influencing COVID-19 Risk: Insights From Molnupiravir Exposure-Response Modeling of Clinical OutcomesAkshita Chawla, Ruthie Birger, Hong Wan, et al.
NPJ Systems Biology and Applications|March 6, 2026
Neuro-Dynamic Quantitative Systems Pharmacology (QSP) model describing Alzheimer's disease pathophysiology and treatment effectsYoufang Cao, Brian A Willis, Kanta Horie, et al.
Science Signaling|April 14, 2016
Gβ promotes pheromone receptor polarization and yeast chemotropism by inhibiting receptor phosphorylationAmber Ismael, Wei Tian, Nicholas Waszczak, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 29, 2024
Population pharmacokinetics and exposure-response analyses of safety (ARIA-E and isolated ARIA-H) of lecanemab in subjects with early Alzheimer's diseaseOneeb Majid, Youfang Cao, Brian A Willis, et al.
Plos Computational Biology|June 9, 2021
Mechanistic basis of post-treatment control of SIV after anti-α4β7 antibody therapyChad R Wells, Youfang Cao, David P Durham, et al.
The ISME Journal|October 30, 2009
Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in miceChenhong Zhang, Menghui Zhang, Shengyue Wang, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2022
Safety and Pharmacokinetics of Islatravir in Individuals with Severe Renal InsufficiencyRandolph P Matthews, Youfang Cao, Munjal Patel, et al.
Nature Medicine|April 18, 2017
HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapyJenna B Honeycutt, William O Thayer, Caroline E Baker, et al.
Clinical Pharmacology and Therapeutics|September 16, 2023
Artificial Intelligence for Quantitative Modeling in Drug Discovery and Development: An Innovation and Quality Consortium Perspective on Use Cases and Best PracticesNadia Terranova, Didier Renard, Mohamed H Shahin, et al.
Clinical and Translational Science|March 26, 2025
Comparison of Molnupiravir Exposure-Response Relationships for Virology Response and Mechanism of Action Biomarkers With Clinical Outcomes in Treatment of COVID-19Akshita Chawla, Ruthie Birger, Brian M Maas, et al.
Pageof 6